Haw-Jyh Chiu - Concepedia

Author

Haw-Jyh Chiu

Center for Drug Evaluation and Research

Also Known As

H Chiu, H. Chiu, H.C. Chiu, Haw-Jyh Chiu, Hawjyh Chiu

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Center for Drug Evaluation and Research United States Food and Drug Administration Rutgers, The State University of New Jersey Center for Devices and Radiological Health Environmental and Occupational Health Sciences Institute

About

Haw-Jyh Chiu is an author at Center for Drug Evaluation and Research specializing in medicine, pharmacology, and hepatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	573
2	Hepatology	3	3	374
3	Health Sciences	2	2	199
4	Allergy	1	1	119
5	Immunology	1	1	166

Haw-Jyh Chiu

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
FDA Approval: Blinatumomab Donna Przepiorka, Chia‐Wen Ko, Albert Deisseroth, Clinical Cancer Research	2015	347
Distinct Roles of Tumor Necrosis Factor-α and Nitric Oxide in Acute Liver Injury Induced by Carbon Tetrachloride in Mice Lisa A. Morio, Haw-Jyh Chiu, Karen A. Sprowles, Toxicology and Applied Pharmacology InflammationHepatologyNitrosative StressNitric OxideLiver Physiology	2001	166
FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia R. Angelo de Claro, Karen M. McGinn, Nicole Verdun, Clinical Cancer Research Preclinical TherapeuticsTyrosine KinasePathologyFda ApprovalPharmacotherapy	2015	156
FDA Approval Summary: Fam-Trastuzumab Deruxtecan-Nxki for the Treatment of Unresectable or Metastatic HER2-Positive Breast Cancer Preeti Narayan, Christy Osgood, Harpreet Singh, Clinical Cancer Research	2021	155
Differential Induction of Heme Oxygenase-1 in Macrophages and Hepatocytes during Acetaminophen-Induced Hepatotoxicity in the Rat: Effects of Hemin and Biliverdin Haw-Jyh Chiu, Jennie A. Brittingham, Debra L. Laskin Toxicology and Applied Pharmacology InflammationHepatologyAllergyMedicineLiver Physiology	2002	119
Role of tumor necrosis factor receptor 1 (p55) in hepatocyte proliferation during acetaminophen-induced toxicity in mice Haw-Jyh Chiu, Carol R. Gardner, Donna M. Dambach, Toxicology and Applied Pharmacology InflammationHepatologyMedicineLiver PhysiologyPathology	2003	89
Enzalutamide for Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer Who Have Previously Received Docetaxel: U.S. Food and Drug Administration Drug Approval Summary Yang‐Min Ning, William F. Pierce, V. Ellen Maher, Clinical Cancer Research	2013	65
Role of p55 tumor necrosis factor receptor 1 in acetaminophen-induced antioxidant defense Haw-Jyh Chiu, Carol R. Gardner, Donna M. Dambach, American Journal of Physiology-Gastrointestinal and Liver Physiology	2003	53
FDA Approval Summary: Olaparib in Combination With Abiraterone for Treatment of Patients With <i>BRCA</i>-Mutated Metastatic Castration-Resistant Prostate Cancer Jaleh Fallah, Jianjin Xu, Chana Weinstock, Journal of Clinical Oncology	2023	47
FDA Approval Summary: Pertuzumab, Trastuzumab, and Hyaluronidase–zzxf Injection for Subcutaneous Use in Patients with HER2-positive Breast Cancer Jennifer Gao, Christy Osgood, Yutao Gong, Clinical Cancer Research Breast OncologyPharmacotherapyMetronomic ChemotherapyDermatologyBreast Cancer Indications	2020	43

Page 1